Awin Brings Its Affiliate Platform to Mexico, Connecting Brands With New Audiences
BUSINESS WIRE)--Global affiliate marketing platform Awin today announces its expansion into Mexico, empowering its partners to scale their businesses with new audiences and local partnerships.
"Our investment in local infrastructure and partnerships is already driving real results. We're excited to continue to grow our network and impact across the region."
Since 2000, Awin has steadily expanded its international footprint to meet the rising demand for local affiliate marketing programs. Over the past year alone, the company has seen a 40% surge in brand-to-brand partnerships, as more businesses tap into Awin's 30,000-strong customer base to drive performance-led growth and strike win-win marketing opportunities. Major brands like Sephora, GE Appliances, Booking.com, Warby Parker and Etsy already partner with the platform.
With an established presence in Brazil, Awin's move into Mexico further strengthens its footprint in the LATAM market. The expansion will capitalize on the region's fast-growing ecommerce adoption and the opportunity this provides for its customers globally. The company now operates in over 4 continents and 17 countries worldwide.
'Awin's expansion into Mexico is a major milestone in our global growth strategy,' said Adam Ross, CEO at Awin. 'Mexico represents a significant opportunity for us to serve a customer base that is eager for scalable affiliate marketing solutions with proven ROI. Our investment in local infrastructure and partnerships is already driving real results. We're excited to continue to grow our network and impact across the region.'
'Localization has been key for us in Brazil, and we want to replicate our success story in Mexico,' said Rodrigo Genoveze, Regional Managing Director Latin America at Awin. 'Our objective is working with best-in-class advertisers and affiliate partners to develop performance-based advertising in the market. With our global experience we aim to deliver our company vision within the Mexican market, empowering brands of all sizes to partner with a diverse network of over one million publishers.'
Capitalizing on Mexico's affiliate opportunity
Mexico is rapidly emerging as a thriving hub for affiliate and partner marketing and is increasingly recognized as a significant player in Latin America. Mexico's burgeoning affiliate marketing industry is projected to grow at an estimated compound annual growth rate (CAGR) of 6.7% from 2024 to 2031. This presents significant opportunities for partnerships and makes it an attractive opportunity for brands to drive ROI through performance-based strategies.
'Grupo Xcaret has been a leader in affiliate marketing in Latin America since 2011,' said Michel Cervantes Martínez, Director of Customer Acquisition at Grupo Xcaret. 'In 2024, we partnered with Awin to take that success even further, combining innovative technology with personalized service to expand into key markets like the United States, Canada and Europe. This collaboration ensures strong ROI and supports our broader business goals.'
'As a publisher, Awin has been a great partner growing affiliate marketing in Mexico and helping accelerate the development of the channel in the country. We really value the quality programs, good communication and reliability Awin offers,' said Willy Ojeda, Founder of Promodescuentos.
Backed by Awin's recent achievements
The news comes on the heels of recent industry accolades, including recognition by G2's 2025 Best Software Awards. Additionally, so far this year, Awin has upgraded more than 400 ShareASale advertisers to its platform and announced a suite of new innovations that underscore its commitment to meeting its customers' evolving needs. Advertisers and publishers now have access to Ava – a fully-integrated intuitive AI-powered assistant. Users also benefit from enhanced commission flexibility and tracking features, as well as advanced real-time performance insights.
To learn more about Awin's global expansion, please visit: https://awin.link/mexico-expansion-us.
About Awin
Got an ecommerce challenge? Awin has the solution. Using Awin's affiliate marketing platform, brands of all sizes can unlock unlimited marketing opportunities that reach consumers everywhere. Choose which affiliate partners best match marketing objectives. Control costs by defining how these partners are paid. And customize affiliate marketing programs using Awin's tech to mirror unique goals, whatever they may be.
For more information, please visit https://awin.link/mexico-expansion-us.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
29 minutes ago
- Business Wire
Eurofins: Purchases of Own Shares From June 16th to June 20th 2025
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Transaction details In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website:
Business Wire
29 minutes ago
- Business Wire
KBRA Assigns Preliminary Ratings to BRAVO Residential Funding Trust 2025-NQM6 (BRAVO 2025-NQM6)
NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to ten classes of mortgage-backed notes from BRAVO Residential Funding Trust 2025-NQM6 (BRAVO 2025-NQM6). The $366.3 million RMBS transaction is collateralized by a pool of 630 residential mortgages, with fixed-rate mortgages (FRMs) and hybrid adjustable-rate mortgages (ARMs) making up 94.4% and 5.6% of the pool, respectively. Most loans are either classified as non-qualified mortgages (Non-QM) (47.0%) or exempt (38.5%) from the Ability-to-Repay/Qualified Mortgage (ATR/QM) rule due to being originated for non-consumer loan purposes. KBRA's rating approach incorporated loan-level analysis of the mortgage pool through its Residential Asset Loss Model (REALM), an examination of the results from third-party loan file due diligence, cash flow modeling analysis of the transaction's payment structure, reviews of key transaction parties and an assessment of the transaction's legal structure and documentation. This analysis is further described in our U.S. RMBS Rating Methodology. To access ratings and relevant documents, click here. Click here to view the report. Related Publications Methodologies Disclosures Further information on key credit considerations, sensitivity analyses that consider what factors can affect these credit ratings and how they could lead to an upgrade or a downgrade, and ESG factors (where they are a key driver behind the change to the credit rating or rating outlook) can be found in the full rating report referenced above. A description of all substantially material sources that were used to prepare the credit rating and information on the methodology(ies) (inclusive of any material models and sensitivity analyses of the relevant key rating assumptions, as applicable) used in determining the credit rating is available in the Information Disclosure Form(s) located here. Information on the meaning of each rating category can be located here. Further disclosures relating to this rating action are available in the Information Disclosure Form(s) referenced above. Additional information regarding KBRA policies, methodologies, rating scales and disclosures are available at About KBRA Kroll Bond Rating Agency, LLC (KBRA), one of the major credit rating agencies (CRA), is a full-service CRA registered with the U.S. Securities and Exchange Commission as an NRSRO. Kroll Bond Rating Agency Europe Limited is registered as a CRA with the European Securities and Markets Authority. Kroll Bond Rating Agency UK Limited is registered as a CRA with the UK Financial Conduct Authority. In addition, KBRA is designated as a Designated Rating Organization (DRO) by the Ontario Securities Commission for issuers of asset-backed securities to file a short form prospectus or shelf prospectus. KBRA is also recognized as a Qualified Rating Agency by Taiwan's Financial Supervisory Commission and is recognized by the National Association of Insurance Commissioners as a Credit Rating Provider (CRP) in the U.S. Doc ID: 1010088
Business Wire
30 minutes ago
- Business Wire
Susan G. Komen ® Invests Nearly $11 Million to Accelerate Breakthroughs in Breast Cancer Research
DALLAS--(BUSINESS WIRE)-- Susan G. Komen ®, the world's leading breast cancer organization, announced today that it is awarding $10.8 million in new research grants that will help propel innovative science and deliver hope to those facing the disease. These research grants support 25 cutting-edge projects at 17 prestigious institutions — marking a powerful commitment to improving outcomes for people living with breast cancer today and in the future. 'We are proud to support these exceptional researchers who are pushing the boundaries of what's possible in breast cancer science,' said Paula Schneider, President and CEO of Susan G. Komen. 'Research saves lives, and now more than ever, we must invest in science that brings hope to patients — especially those facing the most aggressive forms of breast cancer.' Through this research investment, Komen is prioritizing the most pressing challenges facing patients, including metastatic breast cancer, health inequities and the need for more precise, personalized treatment strategies to improve care and outcomes for everyone impacted by breast cancer. Key Highlights of Komen's 2025 Research Investment: 54% of funding targets metastatic breast cancer — the most advanced stage of the disease, responsible for the nearly 43,000 deaths each year in the U.S. 50% focused on precision medicine to tailor treatments to each patient's unique biology. 21% invested in addressing disparities to eliminate inequities in breast cancer care and outcomes. 25 researchers funded, including 10 early-career investigators, representing the next generation of scientific leaders. 'Komen's commitment to breast cancer research comes at a pivotal time and will drive meaningful advances in our understanding of the disease and care of patients,' said Ann Partridge, M.D., M.P.H., Chief Scientific Advisor for Komen. 'By fueling science that is both innovative and inclusive, we're accelerating progress where patients need it most — while building a foundation for individualized care for all.' Komen is the largest nonprofit funder of breast cancer research outside the U.S. government, investing nearly $1.1 billion since its inception. Unlike many research institutions, Komen's work is powered entirely by the generosity of individual donors, corporate partners and community supporters. 'Investing in top scientific talent is one of the most powerful ways we can drive progress,' said Jennifer A. Pietenpol, Ph.D., Chief Scientific Advisor for Komen. 'Komen's commitment, especially to early-career researchers, cultivates a vibrant ecosystem where bold ideas and pioneering research can thrive, accelerating our path toward the cures we urgently seek.' REACHing Deeper into Research Advocacy Komen's commitment to research goes beyond funding — it includes empowering people to bring their lived experiences into the heart of science. Through its recently launched REACH (Research Education and Advocate Community Hub) initiative, Komen invites patients, survivors and co-survivors to become research advocates and help shape research. ShareforCures®, Komen's breast cancer registry, provides breast cancer patients and survivors with a new, secure and easy way to share health data to help accelerate breast cancer research. As Komen deepens its investment in research, the need for collaboration — between scientists, clinicians, advocates and patients — has never been greater. Through strategic funding, innovative patient-centric scientific programs, robust advocacy programs, education and patient support services, Susan G. Komen is leading the way so patients can benefit from scientific breakthroughs and receive the care they need to live longer, healthier lives. Recipients of Komen Grants Recipients of Career Catalyst Research Grants Chun-Kan Chen, PhD, MS, Washington University in St. Louis Miriam Jacobs, MD, Georgetown University Martina Molgora, PhD, MSc., H. Lee Moffitt Cancer Center & Research Institute, Inc. Daniel O'Neil, MD, MPH, Yale University Claire Sathe, MD, JD, Columbia University Irving Medical Center Na Zhao, PhD, Baylor College of Medicine Recipients of Career Transition Awards Charles Dai, MD, Massachusetts General Hospital Avantika Gupta, PhD, MSc, Memorial Sloan-Kettering Cancer Center Alissa Michel, MD, Columbia University Irving Medical Center Veena Padmanaban, PhD, MS, The Rockefeller University Recipients of Leadership Grants Alan Ashworth, PhD, University of California, San Francisco Tuya Pal, MD, Vanderbilt University Medical Center Rulla Tamimi, ScD, MS, Weill Medical College of Cornell University Kornelia Polyak, MD, PhD, Dana-Farber Cancer Institute Christina Curtis, PhD, MSc, Stanford University School of Medicine Jeffrey Rosen, PhD, Baylor College of Medicine Tracy Battaglia, MD, Yale University Allison Kurian, MD, MSc, Stanford University School of Medicine Nancy Lin, MD, Dana-Farber Cancer Institute Ben Ho Park, MD, PhD, Vanderbilt University Medical Center Jennifer Pietenpol, PhD, Vanderbilt University Medical Center Recipients of Opportunity Grants Filipa Lynce, MD, Dana Farber Cancer Institute Michele Cote, PhD, MPH, Indiana University Antonio Wolff, MD, Johns Hopkins University School of Medicine Recipient of Scientific Strategy and Programs Grant Adrian Lee, PhD, University of Pittsburgh To learn more about Komen's research initiatives, visit To explore how you can get involved with REACH (Research Education and Advocate Community Hub), visit About Susan G. Komen ® Susan G. Komen ® is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow's cures. Visit or call 1-877 GO KOMEN. Connect with us on social at
